Pharmacology Flashcards
Pharmacokinetics vs Pharmacodynamics
Pharmacokinetics: What the BODY does TO a drug once it enters the system. Involves absorption, distribution, metabolism, & excretion.
Pharmacodynamics: what the DRUG does TO the body
Absorption
Drug absorbed from site of administration. Faster absorption from IV vs from oral
Distribution: The ___ system sends drug throughout the body. Drugs attach to [large/small] ____ which are produced by the [organ] then are released to travel as an unbound drug to get into certain tissues (e.g. to cross the ___).
The CIRCULATORY system sends drug throughout the body. Drugs attach to LARGE PLASMA PROTEINS which are produced by the LIVER then are released to travel as an unbound drug to get into certain tissues (e.g. to cross the BLOOD BRAIN BARRIER).
In an individual with liver disease, may have FEWER plasma proteins = LESS ABLE TO RETAIN a drug in the circulatory system -> drug may get to tissues FASTER; might need to adjust dosing
Impact of exercise on pharmacokinetics?
Consider absorption, distribution, metabolism, & excretion with the example of injecting insulin into an exercising muscle
Exercise -> Increased tissue HEAT -> increased DIFFUSION across the membranes and into the bloodstream (post insulin injection -> rapid transfer of drug into bloodstream -> could result in hypoglycemia)
Blood is also shunted TOWARD exercising muscle and AWAY from liver & kidneys, which can impact those organs’ roles/efficacy in drug metabolism & excretion
Metabolism: occurs primarily in the [organ]. ____ convert drug from an active -> less active or inactive form.
Impact of aging or disease states on metabolism?
Metabolism: occurs primarily in the LIVER. ENZYMES convert drug from an active -> less active or inactive form.
Older adults may have decreased liver function (due to aging or liver disease). If drug isn’t being metabolized in the liver, it will continue to circulate & exert its effect! May need to adjust dosage.
Excretion: occurs in the [organ]. Water-soluble drugs excreted in ___. Fat soluble drugs are ___ to be further metabolized until more water soluble & able to be excreted by kidneys
May need to adjust dosing for those w/impaired renal function
Excretion: occurs in the KIDNEYS. Water-soluble drugs excreted in URINE. Fat soluble drugs are REABSORBED & RECIRULATED to be further metabolized until more water soluble & able to be excreted by kidneys
May need to adjust dosing for those w/impaired renal function
Therapeutic index is the ratio of ___ over ____.
A wide/large therapeutic index means a drug [is relatively safe / needs to be closely monitored] vs a small therapeutic index means ___.
Therapeutic index = ratio of MEDIAN TOXIC DOSE over MEDIAN EFFECTIVE DOSE.
A wide/large therapeutic index = relatively SAFE
Small/narrow therapeutic index = may require more FREQUENT MONITORING of drug levels in blood (e.g. warfarin)
The median effective dose is when ____.
The median toxic dose is when ___.
Median effective dose = 50% of the population responds to the drug in a desired manner (desired effect)
Median toxic dose = dose at which 50% of population would exhibit toxic effects (not desired)
Acetylcholine
- Involved with the [parsympathetic / sympathetic / both parsympathetic and sympathetic) nervous system(s)
- Activated by _____
- Plays a role in ____
- Involved with ___ (dz)
- Involved with BOTH the parsympathetic AND sympathetic nervous system
- Activated by acetylcholinesterase
- Role in COGNITION & MEMORY
- Involved with ALZHEIMER’S DZ
Dopamine
Important in regulating motor control in the [brain structure].
Important in mood and emotions in [brain structure]
Dopamine:
- Monoamine
- Important in regulating motor control in BASAL GANGLIA
- Important in mood and emotions in HYPOTHALAMUS
Excess dopamine can be involved with ___ (dz)
Too little dopamine is typical in ____ (dz)
Excess dopamine can be involved w/PSYCHOSIS
Too little dopamine is typical in PARKINSON’S DZ
Norepinephrine
- Role in ____ nervous system
- Action ends in reuptake from ___ & storage in ____
Involved with ___ (dz)
Norepinephrine
- Role in AUTONOMIC nervous system
- Action ends in reuptake from SYNAPTIC CLEFT & storage in NEURON
Involved with DEPRESSION
Serotonin
Important w/ ____ & ____ (cog functions)
Involved with ___(dz)
Serotonin
Important w/ MOOD AND BEHAVIOR
Involved with DEPRESSION
Gamma-aminobutyric acid (GABA)
Receptor location?
Involved with ___ (dz)
Gamma-aminobutyric acid (GABA)
Receptors THROUGHOUT CNS
Involved with ANXIETY / SEIZURES / SPASTICITY
Discuss the relationship between dopamine and acetylcholine in Parkinson’s Disease.
In PD, goal is to [increase/decrease] DA, or [increase/decrease] ACh
PD: Progressive degeneration of dopaminergic neurons in BG upsets the balancing effect between DA & ACh in the brain
Address by: INCREASING DA vs DECREASING ACh
Levadopa-carbadopa is the mainstay in the treatment of PD. What’s the purpose of the levadopa? The carbadopa?
Levadopa: is a dopamine precursor, can cross the blood brain barrier, where it is converted to dopamine by the dopa decarboxylase enzyme in brain
Carbadopa: deactivates the dopa decarboxylase enzyme in the blood stream -> allows L-DOPA to move into brain & be beneficial!
At high doses of levadopa, we can see undesirable GI side effects? Why? What can help to prevent that?
Dopa decarboxylase (breaks down L-DOPA -> dopamine) exists both in the blood stream and in the brain. With levadopa alone, you need a large enough dose of L-DOPA to make sure enough gets across the blood brain barrier to be beneficial in the brain. BUT this large dose can -> undesirable GI side effects
Solution: Carbadopa acts to deactivate the dopa decarboxylase enzyme in the blood stream -> allows L-DOPA to move into brain & be beneficial!
Peak sinemet timing is ____ post administration
Peak sinemet timing is 1 HOUR post administration
Sinemet side effects
- Cardiovascular
- GI
- Behavioral
- Neuro
Sinemet Side effects:
- Cardiovascular: arrhythmias, postural hypotension; monitor BP closely
- GI: nausea/vomiting
- Behavioral: anxiety, depression, confusion, hallucinations
Neuro: Dyskinesias: tics, tremors, choreoathetoid movements; onset >=5 years after initiation of dopamine-replacement therapy. Common w/those diagnosed at younger age or those who need higher levels of dopa.
What is the role of dopamine agonists in the treatment of PD?
- Mechanism of action?
- Benefits?
- Examples (drug names)?
- Side effects?
DA Agonists
Action: Bind and activate post-synaptic dopamine receptors.
Use: monotherapy in early PD & <65yo, OR combination therapy later in disease to decrease dose of levadopa needed
Benefits: Longer half life, sustained stimulation of dopamine
Examples:
Bromocriptine (Parlodel)
Pramipexole (Mirapex)
Ropinirole (Requip)
Side effects: (similar to Sinemet/L-Dopa)
Cardiovascular: arrhythmias, postural hypotension; monitor BP closely
GI: nausea/vomiting
Behavioral: anxiety, depression, confusion, hallucinations
Dyskinesias: tics, tremors, choreoathetoid movements; onset >=5 years after initiation of dopamine-replacement therapy. Common w/those diagnosed at younger age or those who need higher levels of dopa.
Impulse control disorders (e.g. compulsive buying, gambling, impulsive sexual behaviors)